Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663

Watchlist Manager
Bharat Immunologicals and Biologicals Corporation Ltd Logo
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
Watchlist
Price: 17.48 INR 1.63% Market Closed
Market Cap: ₹754.8m

Operating Margin

-265.1%
Current
Declining
by 168.5%
vs 3-y average of -96.6%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-265.1%
=
Operating Income
₹-202.8m
/
Revenue
₹76.5m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-265.1%
=
Operating Income
₹-202.8m
/
Revenue
₹76.5m

Peer Comparison

Country Company Market Cap Operating
Margin
IN
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
742.7m INR
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
387B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.5B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
174.7B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
121.5B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.2B USD
Loading...
AU
CSL Ltd
ASX:CSL
87.1B AUD
Loading...
NL
argenx SE
XBRU:ARGX
44B EUR
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...

Market Distribution

Lower than 96% of companies in India
Percentile
4th
Based on 5 437 companies
4th percentile
-265.1%
Low
-153 833.3% — 2.7%
Typical Range
2.7% — 13.2%
High
13.2% — 9 977%
Distribution Statistics
India
Min -153 833.3%
30th Percentile 2.7%
Median 7.3%
70th Percentile 13.2%
Max 9 977%

Bharat Immunologicals and Biologicals Corporation Ltd
Glance View

Market Cap
754.8m INR
Industry
Biotechnology

Bharat Immunologicals & Biologicals Corp. Ltd. is a biotechnology company, which engages in the manufacture and market of pharmaceutical products. The company is headquartered in Bulandshahr, Uttar Pradesh. The firm is primarily engaged in the manufacture of Oral polio Vaccine, Zinc Tablets, Diarrhea management Kit and BIB Sweet Tablets. The company is also focused on manufacturing Ready to Use Therapeutic Food (RUTF), which is used for the treatment of malnourishment among various acute malnourished children. The firm is switched over to bivalent oral polio vaccine (bOPV) from trivalent oral polio vaccine (tOPV). The company is also diversified into Plasma-derived medicines and Oral Cholera vaccines. The firm's manufacturing unit is located at Village Chola, Bulandshahr, Uttar Pradesh, India.

BIBCL Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-265.1%
=
Operating Income
₹-202.8m
/
Revenue
₹76.5m
What is Bharat Immunologicals and Biologicals Corporation Ltd's current Operating Margin?

The current Operating Margin for Bharat Immunologicals and Biologicals Corporation Ltd is -265.1%, which is below its 3-year median of -96.6%.

How has Operating Margin changed over time?

Over the last 3 years, Bharat Immunologicals and Biologicals Corporation Ltd’s Operating Margin has decreased from -2% to -265.1%. During this period, it reached a low of -265.1% on Oct 30, 2023 and a high of -2% on Aug 30, 2020.

Back to Top